ClinicalTrials.govpublic full text
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
thrombocytopenia, cytarabine causing adverse effects in therapeutic use, lymphoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 831895
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.